Drugs / JZP541
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05733390 | Jun → Nov 2023 | autism | Jazz Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JZP541 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05733390 ↗ |
| Route | Oral | “Oral suspension” NCT05733390 ↗ |